A full-length reverse-transcribed, infectious cDNA copy of coxsackievirus B3 (CVB3) was used to determine the nucleotide sequence of this cardiotropic enterovirus. Comparison of the nucleotide sequence and the deduced amino acid sequence of the viral precursor polyprotein with the sequences of other group B coxsackieviruses (CVB1 and CVB4) demonstrates a high degree of genetic identity. They share about 80% homology at the nucleotide level and about 90% when the amino acid sequences of the polyproteins are compared. The potential processing sites of the coxsackievirus polyproteins, as deduced from alignment with the poliovirus sequence, are conserved among these enteroviruses with the exception of the cleavage sites between VP1 and 2APro and between polypeptides 2B and 2C. Comparison of the 5' termini of the enteroviral genomes reveals a high degree of identity, including the initial 5' consensus UUAAAACAGC, suggesting essential functions in virus replication. An important finding concerning the molecular basis of infectivity was that both recombinant CVB3 cDNA and in vitro-synthesized CVB3 RNA transcripts are infectious, although two initial 5' uridine residues found on the authentic CVB3 RNA were missing. Here, we report that cDNA-generated CVB3, as well as CVB3 generated by in vitro-synthesized RNA transcripts, regains the authentic initial 5' uridine residues during replication in transfected cells, indicating that the picornaviral primer molecule VPg-pUpU may be uridylylated in a template-independent fashion. The generation of virus or virus mutants with infectious recombinant CVB3 cDNA and in vitro-synthesized infectious CVB3 transcripts should provide a valuable means for studying the molecular basis of the pathogenicity of this cardiotropic enterovirus.
Enteroviruses of the human Picornaviridae, such as the group B coxsackieviruses (types 1 to 5), are the most common agents known to cause viral myocarditis (1, 12, 24, 34, 53) . Other human enteroviruses, comprising at present over 70 serotypes (e.g., various group A coxsackieviruses and echoviruses), have also been associated with human heart disease. These agents are capable of producing dilated cardiomyopathy of acute onset or leading to life-threatening arrhythmias. Particularly intriguing is the concept of enterovirus persistence in chronic dilated cardiomyopathy evolving from acute or subacute infections of the human heart (13, 17) .
The structure and molecular genetics of the enteroviruses are well understood, chiefly by analogy with the extensively studied poliovirus (for a review, see reference 52) . The coxsackieviruses possess a single-stranded RNA genome of about 7,500 nucleotides (nts) of positive polarity, which is covalently linked at the 5' end to a small virus-encoded protein, VPg (3B, according to the systematic nomenclature of picornavirus proteins [36] ). The viral RNA, which is infectious (22, 39) , is polyadenylylated at the 3' end and functions as an mRNA in the cytoplasm of infected cells. It is translated into a large precursor polyprotein, which is processed by virus-encoded proteinases to yield the mature structural and nonstructural proteins (19) . Replication of picornaviral RNA has been studied extensively (52, and references therein), although the individual steps in RNA and possibly other virus-or host cell-encoded factors (2, 27, 52, 55) .
In order to study the molecular basis of pathogenicity and to introduce in situ hybridization as a diagnostic tool in patients with a clinical suspicion of enteroviral heart disease, we have previously cloned the genome of the cardiotropic coxsackievirus B3 (CVB3), which had been propagated in cultured human myocardial cells (14) (15) (16) . Full-length reverse-transcribed recombinant cDNA generated infectious virus antigenically identical to CVB3 upon transfection into mammalian cells, demonstrating the biological intactness of the cloned cDNA copy. The isolation of cDNA fragments representing the genomic RNA of CVB3 has also been described by others (20, 48) , and a nucleotide sequence of CVB3 based on subgenomic cDNA fragments has been reported by Lindberg et al. (20) . We now present the entire nucleotide sequence of infectious, full-length reverse-transcribed recombinant CVB3 cDNA and have compared this with that of other human enteroviral genomes.
In this context, we report on transfection experiments with circular recombinant CVB3 cDNA and in vitro-synthesized CVB3 RNA transcripts, demonstrating that inherent infectivity of these CVB3 constructs is independent of the presence of two initial 5' uridine residues found on the authentic viral RNA. Remarkably, the authentic viral 5' terminus is restored in the RNA genome of both cDNA-derived CVB3, as well as in vitro-synthesized RNA-derived virus progeny.
MATERIALS AND METHODS
Sequence determination. Full-length reverse-transcribed, infectious CVB3 cDNA (16) was used to determine the nucleotide sequence of CVB3. For this purpose, subgenomic CVB3 cDNA fragments were inserted into the SmaI site of pUC19 (54) and sequenced by the chain termination method (3, 37) . Fragments from the cloned CVB3 cDNA were generated by digestion with BglI or PvuII and subsequent incubation with nuclease Bal 31 or by digestion with one of the frequently cleaving restriction endonucleases, HaeIII, AluI, and RsaI. A total of 93% of the CVB3 nucleotide sequence was obtained from both strands, and the remainder was obtained from multiple determinations on one strand of at least two independent subclones.
To determine the sequence of the very 5' end of the viral genome, 1 ,ug of purified CVB3 RNA (16) was primed with an 18-base-long synthetic oligonucleotide, complementary to a region of viral RNA comprising nucleotide positions 62 to 78. Single-stranded cDNA was synthesized with reverse transcriptase as previously described (16) . The primer-extended cDNA was separated on an 8% denaturating polyacrylamide gel and sequenced by the method of Maxam and Gilbert (23 (56) .
Plasmid construction. A 7.5-kilobase EcoRI fragment obtained by partial digestion of the infectious CVB3 cDNA plasmid pCB3-M1 (16) was inserted in both orientations into the dual-promoter plasmid pSPT18 (constructed at Pharmacia) containing both the SP6 and T7 promoter sequences, diametrically opposed and separated by the multiple cloning site of pUC-18 (54) . The resulting recombinant plasmids were designated pCB3/T7 and pCB3/SP6 ( Fig. 1) and allowed the in vitro synthesis of plus-strand CVB3 RNA under the control of the T7 and SP6 promoter, respectively, whereas minus-strand transcripts are synthesized under the control of the opposite promoter. The nucleotide sequences at the ligation junctions were determined directly from plasmid DNA (3). The T7 promoter of pCB3/T7 directs synthesis of plus-strand transcripts with 34 nonviral nts at the 5' end. pCB3/SP6-derived SP6 transcripts contain 82 nonviral nucleotides at the 5' end (see legend to Fig. 1 ). Both plasmids, pCB3/T7 and pCB3/SP6, were found to be infectious upon transfection into HeLa cells.
In vitro transcription. Plasmid pCB3/T7 was digested with Sall [cuts 65 nts after the 3' poly(A) tail], and the resulting linear DNA was isolated by phenol extraction and ethanol precipitation. RNA transcription was carried out essentially as described previously (4, 50) . Briefly, 1 ,ug of Sall-digested pCB3/T7 DNA served as a template for plus-strand RNA synthesis with T7 polymerase (400 U/ml) for 60 min at 37°C in 50 RI that contained 40 (20, 48) (Fig. 3 ). This frameshift results in an altered peptide sequence of 12 (10) , CVB4 (83%) (11) , and, less pronounced, with poliovirus type 1 (PV1) (50%) (18, 32) , whereas the previously reported CVB3 sequences (20, 48) clearly deviate (Fig. 3 ).
Sequence comparison with other group B coxsackieviruses. Comparison of the nucleotide sequence of the CVB3 genome with the sequences of the potentially cardiotropic CVB1 and CVB4 (compare the sequences in Fig. 2 ) revealed high degrees of overall identity, 80.7 and 78.3%, respectively. The nc regions are highly conserved among the coxsackieviruses: CVB3-to-CVB1 identity, 94.1% (5' nc) and 89.4% (3' nc); CVB3-to-CVB4 identity, 83.4% (5' nc) and 92.3% (3' nc). One insertion (CVB4, 1 nt after position 32) and three deletions (CVB3, 1 nt after position 115; CVB1, 1 nt each at positions 118 and 7399) were observed within the 5' nc and 3' nc regions, respectively.
The majority of nucleotide differences among group B coxsackieviruses appear to be almost evenly distributed over the entire open reading frame encoding the viral polyprotein and occur frequently (71.3%) at third-nucleotide positions. As expected, the regions coding for the structural proteins VP1, VP2, and VP3 are less conserved than the regions coding for VP4 and the nonstructural proteins. Notable deletions and insertions are observed in the coding regions of VP1 and VP2. A total of 15 nts are inserted within the gene region of VP1 of CVB4 (after nt 2703), 6 nts are deleted within VP1 (nt 2673 and nts 2680 through 2684) and VP2 of CVB4 (nt 1404 and nts 1414 through 1418), and 9 nts are inserted within VP1 of CVB3 (nts 3283 through 3291).
Alignment of the deduced CVB3 polyprotein sequence with those of CVB1, CVB4, and PV1 (Fig. 4) allows the identification of putative cleavage sites. In comparison to those of PV1, cleavage sites are conserved, with the exception of the cleavage sites between polypeptides 2B and 2C (2B/2C) and between VP1 and 2APrO (VP1/2APrO). In PV1, 2B/2C is a target of the 3C proteinase (3CPrO) (8) . However, a Q-N pair is found to be present in CVB3, CVB1, and CVB4 at a position corresponding to the Q-G cleavage site of PV1. Since no alternative Q-G site is found at a proximal position, we suggest that the Q-N pair is cleaved by the coxsackievirus 3CPro, generating termini of polypeptides 2B and 2C at equivalent positions with respect to PV1.
In the case of poliovirus, the cleavage between VP1 and 2APrO is mediated by 2APro, leading to the proper release of the structural precursor protein P1 (46) . In comparison to the Y-G cleavage site of PV1 comprising the cleavage between VP1 and 2APrO, the corresponding amino acids are not conserved among the group B coxsackieviruses (Fig. 4) . Assuming cleavage sites with properties similar to the poliovirus Y-G pair (aromatic amino acid-G), the F (or Y)-G pairs located two residues downstream with respect to PV1 would represent suitable cleavage sites in the group B coxsackieviruses. Alternatively, the T-G pair (two residues upstream) has been suggested (10, 30) . To verify the proposed cleavage site for CVB3, protein sequence studies are required.
The alignment of the polypeptides of CVB1, CVB3, CVB4, and PV1 (Fig. 4) indicates that identity among the coxsackieviral polyproteins is clearly higher compared with that of PV1. Taking into consideration the deduced cleavage sites of the polyproteins, the degree of identity among the viral proteins has been determined and is summarized in [10] ) and CVB4 (bottom) (Jenkins et al. [11] ). The CVB3 sequence is shown in its entirety together with the corresponding nucleotide changes of CVB1 and CVB4. The gene regions of the distinct viral proteins are defined by vertical lines by analogy to the poliovirus genome (18, 32 64, 1990 INFECTIOUS COXSACKIEVIRUS B3 cDNA
CCCUCC _~~~~~~~~~~~~~~~~~~~~~~~~--AUUGAUAUtGUGC peptide sequences are found corresponding to the antiparallel oriented beta strands and short alpha helices which determine the core structure of PV1 capsid proteins (9 Fig. 1 ). These RNA n 2APro of infectious molecules also lacked the two 5' uridine residues and conuences. The deduced tained additional nonviral nucleotides at both ends. A spe-;DNA presented here cific infectivity of 14 to 30 PFU/,ug of T7-and SP6-derived CVB1 (10) (Fig. 6 ). DISCUSSION Picornavirus research is in a very dynamic phase following the demonstration that cloned cDNA copies of poliovirus (33) and CVB3 (16) and in vitro-synthesized RNA transcripts of poliovirus (50), human rhinovirus 14 (26) , and hepatitis A virus (4) are infectious. In addition, recombinant DNA techniques have contributed to an improved diagnosis of picornavirus infections. We have previously developed an in situ hybridization assay capable of detecting enterovirus RNA in myocardial tissue with full-length reverse-transcribed recombinant CVB3 cDNA as an enterovirus groupspecific probe (14) . By this approach, the presence of enterovirus RNA has been assessed in endomyocardial biopsy samples of a significant number of patients with myocarditis or dilated cardiomyopathy or both (13, 17) .
By comparison of the CVB3 genome to those of other VOL. 64, 1990 INFECTIOUS COXSACKIEVIRUS B3 cDNA 1579 [11] ), and PV1 (18, 32 potentially cardiotropic group B coxsackieviruses, the high degree of identity among nucleotide and amino acid sequences clearly demonstrates their close genetic relationship, which is considerably lower with respect to poliovirus (compare Table 1 with Fig. 4 ). Most pronounced is the degree of identity within the 5' and 3' nc regions and, regarding the polyprotein sequences, within the nonstructural proteins and VP4. In the case of the structural proteins VP1, VP2, and VP3, identity is confined to distinct regions interspersed between nonhomologous sequences (Fig. 4) . As is evident from the crystallographic structures of various picornaviruses (9, 21, 35) , conserved regions have an impor- (40) , human rhinovirus type 2 (HRV2) (38) , and hepatitis A viruses (HAV/LA) (28) and HAV/MBB (31) are presented. Note that the first 10 nts at the 5' end are identical among the enteroviruses. Arrows indicate perfect repeats of inverted symmetry, 6 to 10 nts in length, which are found at corresponding positions for the human enteroviruses and rhinoviruses (nts 9 to 20 are complementary to nts 23 to 37, and nts 2 to 11 are complementary to nts 75 to 88). In the case of hepatitis A virus, the inverted repeat that is complementary to nts 2 to 11 is shifted to nts 31 to 39. Computer-calculated secondary structures (data not shown) suggest an important function for these inverted repeats during plus-and minus-strand RNA replication.
FIG. 7.
Plaque morphology of CVB3 generated through transfection of wild-type RNA (A), recombinant pCB3-M1 plasmid DNA (B), recombinant pCB3/T7 plasmid DNA (C), and in vitro-synthesized CVB3 RNA (D). HeLa cell monolayers were infected with transfection-derived first-passage stocks, as described for plaque assays in Materials and Methods, indicating that viruses generated in the absence of two initial 5' uridine residues exhibited wild-type plaque morphology. tant function in maintaining polypeptide chains of the structural proteins in the barrel-like core structure. Structurally conserved loops and terminal extensions have been suggested to be involved in dynamic viral processes, e.g., assembly, receptor binding, and uncoating (7), whereas highly divergent sequences may participate in the formation of antigenic determinants. This pattern of conserved and heterologous peptide sequences is shared by various genera of picornaviruses, as demonstrated by a comprehensive alignment of the capsid proteins of 33 picornavirus strains (30) . Peptide sequences, which can be identified by correlation to poliovirus sequences containing antigenic determinants, are highly divergent among the coxsackieviruses and probably exhibit serotype-specific antigenic properties. In addition, peptides with sequences common to a subset of serotypes should provide useful targets for broad-spectrum clinical diagnosis of potentially cardiotropic enteroviruses. In this context, we have recently demonstrated that polyclonal antibodies generated against bacterially synthesized fusion proteins of various CVB3 structural proteins clearly cross-react with a wide variety of group A and B coxsackieviruses, as well as echoviruses (51) .
The mechanism by which the recombinant cDNA of a picornavirus initiates an infectious cycle in transfected cells is currently poorly understood. Presumably, the recombinant cDNA is transcribed in the nucleus of transfected cells to produce plus-strand RNA transcripts, which serve as messengers for the synthesis of virus-directed proteins and as templates for replication. Regardless of whether these transcripts are initiated from cellular promoters after integration or from cryptic promoters present in the vector DNA, they probably represent oversized transcripts with extra nonviral sequences at both ends. The in vitro-synthesized CVB3 RNA transcripts also represent oversized transcripts. These RNAs, while about 20 times more infectious than the plasmid DNAs, are only about 0.01% as infectious as RNA isolated from the virus. This may be caused by the presence of oversized nonviral sequences (50) and possibly also by the absence of two initial 5' uridine residues. Nonetheless, transfection-derived viruses have biological properties indistinguishable from those of parental CVB3.
The 5' termini of the transfection-derived viruses and that of parental CVB3 were found to be identical, demonstrating that recombinant plasmid DNA, as well as in vitro-synthesized RNA transcripts, has regained two initial 5' uridine residues during initiation of an infectious cycle. Presumably, these uridine residues are provided by the picornaviral nucleotidyl protein VPg-pUpU, which has been proposed as a component of the initiation complex of poliovirus RNA synthesis (5, 43, 44, 52) . Free VPg-pUpU is known to be present in poliovirus-infected cells (5) and has been synthesized in vitro in a membrane fraction of poliovirus-infected cells (43) . It was suggested that a precursor of VPg, most likely polypeptide 3AB, is uridylylated and subsequently cleaved by the 3C protease (3CPrO) to yield the primer molecule VPg-pUpU (44, 52) . In vitro pulse-chase analyses have supported a model in which VPg-pUpU can function as a primer in the elongation reaction (42) , and evidence was obtained by an in vitro genetic approach that implicates 3DPOI in the formation of VPg-pUpU (47) . Thus, a very attractive model for the initiation of picornaviral RNA synthesis is provided by implying synthesis of VPg-pUpU by 3D"' without a template, by its hybridization to template RNA, and by elongation by 3DP01.
Our finding of a correct 5' end of transfection-derived CVB3 strongly supports uridylylation of VPg in a templateindependent fashion. This implies a unique mechanism allowing the correct initiation of plus-strand RNA synthesis independent of the presence of two complementary adenines of the minus strand. Presumably, distinct sequences of the minus-strand RNA template are involved in this process by interacting with components of the replication complex. The inverted repeats identified near the 5' terminus of the viral genome (compare structures shown in Fig. 5 ) might play an important role. It is tempting to assume that these sequences, as part of the minus strand, might adopt a distinct three-dimensional arrangement serving as a signal element for the interaction with protein entities of the putative replication complex.
The availability of the nucleotide sequence of an infectious cDNA clone of a cardiotropic CVB3 should prove to be useful for further studies on the structure and function of the viral RNA and provides a basis for a molecular genetic approach not previously available for the analysis of enterovirus-induced cardiomyopathy.
